UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549


_____________________________
OMB APPROVAL
OMB NUMBER: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response....11
_____________________________


                                 SCHEDULE 13G/A





                   Under the Securities Exchange Act of 1934
                         (Amendment No. 7   )*


                    	BOSTON LIFE SCIENCES, INC.
             -----------------------------------------------------
                                (Name of Issuer)

                 		COMMON STOCK
             -----------------------------------------------------
                         (Title of Class of Securities)

                   		100843408
             -----------------------------------------------------
                                 (CUSIP Number)

					2/11/05
             -----------------------------------------------------
            (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

[] Rule 13d-1(b)
[X] Rule 13d-1(c)
[] Rule 13d-1(d)



- ----------
*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any  subsequent  amendment  containing  information  which  would  alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).




CUSIP No.  100843408



- --------------------------------------------------------------------------------
   1.  NAME OF REPORTING PERSON(S)
       S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON(S)

	ROBERT L. GIPSON



- --------------------------------------------------------------------------------
   2.  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

         (a)  [  ]
         (b)  [  ]


- --------------------------------------------------------------------------------
   3.  SEC USE ONLY




- --------------------------------------------------------------------------------
   4.  CITIZENSHIP OR PLACE OF ORGANIZATION


     UNITED STATES OF AMERICA

- --------------------------------------------------------------------------------
   NUMBER OF      5.   SOLE VOTING POWER
     SHARES             576,800
BENEFICIALLY    --------------------------------------------------------------
    OWNED BY      6.   SHARED VOTING POWER
      EACH              100,000  (see item 6)
   REPORTING      --------------------------------------------------------------
     PERSON       7.   SOLE DISPOSITIVE POWER
      WITH              576,800
- --------------------------------------------------------------
                  8.   SHARED DISPOSITIVE POWER

                   112,000  (See Item 6)
- --------------------------------------------------------------------------------
   9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                   688,800 (See Item 6)
- --------------------------------------------------------------------------------
  10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*



- --------------------------------------------------------------------------------
  11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

                  9.6 %   (see Item 6)
- --------------------------------------------------------------------------------
  12.  TYPE OF REPORTING PERSON*

                  IN
- --------------------------------------------------------------------------------


Item 1.     (a)   Name of Issuer:

                 	BOSTON LIFE SCIENCES INC.
                  --------------------------------------------------------------
            (b)   Address of Issuer's Principal Executive Offices:

                	20 NEWBURY ST
			BOSTON, MA 02116
                  --------------------------------------------------------------
Item 2.     (a)   Name of Person Filing:


	           ROBERT L. GIPSON
                  --------------------------------------------------------------
            (b)   Address of Principal Business Office, or if None, Residence:


	          C/O INGALLS & SNYDER LLC
	          61 BROADWAY, NEW YORK, NY 10006




                  --------------------------------------------------------------
            (c)   Citizenship:
                             USA
                  --------------------------------------------------------------
            (d)   Title of Class of Securities:
                  		COMMON STOCK
                  --------------------------------------------------------------
            (e)   CUSIP Number:
                                100843408
                  --------------------------------------------------------------
Item 3.



Item 4.     Ownership.

Incorporated by reference to Items (5)-(9) and (11) of the cover
page.


Item 5.     Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following [ ].
		INAPPLICABLE

Item 6.     Ownership of More Than Five Percent on Behalf of Another Person.


Shares reported under sole voting and sole dispositve authority include common
shares owned by Gipson and shares issuable in exchange for 50,000 BLSI
warrants which give him the right to a acquire one share per warrant
(on a pre-reverse-split basis) at a price of $2.15 until 03/01/07.
Shares reported under shared voting and shared dispositve authority include
those owned by clients of Ingalls & Snyder LLC, a broker/dealer and a
registered investment advisor, in accounts over which Gipson has voting
and/or discretionaryinvestment authority.  Gipson is a Senior Director
of Ingalls & Snyder LLC.

All shares reported assume the exercise of all warrants owned by Gipson.




Item 7.     Identification and Classification of the Subsidiary which Acquired
            the Security Being Reported on By the Parent Holding Company.

		INAPPLICABLE

Item 8.     Identification and Classification of Members of the Group.

		INAPPLICABLE

Item 9.     Notice of Dissolution of Group.

		INAPPLICABLE


Item 10.    Certification.



            By  signing  below I certify  that,  to the  best  of  my knowledge
and belief, the securities referred to above were acquired and are held in the
ordinary  course of business  and were not  acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities  and were not acquired and are not held in connection
with or as a participant in any  transaction  having that purpose or effect.

                                  Signature.


            After reasonable inquiry and to the best of my knowledge and
            belief, I certify  that the  information  set  forth in this
            statement is true, complete and correct.

Date: 02/11/05


BY:
/s/ ROBERT L. GIPSON
- ----------------------------------
                      (Signature)*
ROBERT L. GIPSON
- ----------------------------------
                      (Name/Title)